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Objectives: To analyze the expression of the 15- to 17-kDa plasmid-encoded antigens from Rhodococcus equi isolates 
of 7 AIDS patients and determine the immunologic response to these proteins in the patients' sera. 
Methods: The expression of the virulence proteins in R. equi isolates and the specific antibody response were 
investigated by immunoblotting. Plasmid DNA was analyzed by agarose gel electrophoresis. 
Results: The only patient infected with a strain carrying the virulence 85-kb plasmid and expressing the 15- to 17-kDa 
antigens developed a fatal pneumonia and did not produce specific antibodies to the virulence proteins. Of the 6 patients 
infected with R. equistrains lacking both proteins and plasmid, only 1 subject had a pulmonary disease with poor clinical 
outcome and exhibited a negligible humoral immune response to R. equi antigenic components, whereas the other 
patients who produced a remarkable antibody response developed either an asymptomatic infection (1 case) or 
pneumonia (4 cases) which completely cleared up. 
Conclusions: Our findings suggest that R. equi disease can be induced without the expression of the 15- to 17-kDa 
virulence-associated plasmid-encoded antigens in HIV-infected patients with very low CD4+ cell counts. Nevertheless, 
both the synthesis of the virulence proteins and a defective humoral immune response to R. equi may contribute to the 
severity of rhodococcal disease. 
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Rhodococcus equi is a facultative, intracellular, gram- 
positive coccobacillus that can cause severe pneumonia 
and lung abscesses in 1- to 3-month-old foals. Initially 
described as an animal pathogen, it is now recog- 
nized as an emerging opportunistic pathogen in 
immuno-compromised humans, in whom a similar 
pneumonia frequently occurs (1, 2). At present, R. eqtri 
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is increasingly isolated from sputum or blood cultures 
from patients with AIDS. In these subjects, the 
pulmonary disease is characterized by frequent relapses 
and a high mortality rate, despite continuous anti- 
microbial therapy and surgical intervention. 
Bacterial virulence factors and host immunity 
play an important role in the pathogenesis of R. equi 
infections. The virulence of R. equi in both mice and 
horses has been shown to be directly associated with 
the expression of 15- to 17-kDa surface protein anti- 
gens encoded by a large plasmid of approximately 
85 kb (3-5). The virulence-associated plasmid-encoded 
antigens, which are temperature-regulated and are 
located on the external surface of cells (6), have 
also been used as markers for the identification of 
virulent isolates from horses and their environment. 
Moreover, immunoblotting experiments have demon- 
strated that foals naturally infected with R. equi 
produced a remarkable antibody response to these 
proteins (3) .  The importance of 15- to 17-kDa antigens 
as virulence factors in human R. eqtri infections as well 
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as their immunogenicity in infected patients remain to 
be determined. 
The aim of this study was to analyze the expression 
of the 15- to 17-kDa plasmid-encoded antigens in 
R. equi isolates from AIDS patients and to determine 
the immunologic response to these proteins in the 
patients' sera. The correlation between these data and 
the clinical outcome of rhodococcal disease was also 
evaluated. 
Materials and Methods 
Bacteria 
R. equi reference strain ATCC 33701, which was 
previously found to be virulent in a mouse model(3), 
was obtained from American Type Culture Collection 
(Rockville, MD). Clinical strains (5683D, 212B, 239D, 
2275B, 2633C, 210D, 605B) were isolated from the 
sputum of 7 different patients with AIDS and identified 
as R. equi by the API Corynebacterium test results 
(Biomkrieux, Marcy l'Etoile, France). Strains were 
subcultured no more than 3 times and stored in aliquots 
with 15% glycerol at -8OOC. 
Sera 
Serum samples were collected from a foal naturally 
infected with R. equi and from the 7 culture-positive 
AIDS patients. 
lmmunoblotting 
Whole-cell antigens were prepared by harvesting 
bacteria grown at 38°C for 48 h in brain heart infusion 
broth. Samples were sonicated and solubilized in 
3% SDS reducing buffer with 5% 2-mercaptoethanol. 
The lysates were boiled for 20 min. and centrifuged 
at 12,000 g for 5 min. to remove debris. Lysates 
containing approximately 2 x 108 cells per well were 
separated by SDS-PAGE' with a running gel and a 
stacking gel of 13% and 4% acrylamide respectively, and 
electro-transferred to nitrocellulose for immunoblot 
analysis. The blotted nitrocellulose sheets were blocked 
with 0.25% PBS-Tween for 60 min. at room tempera- 
ture and incubated overnight at room temperature with 
serum samples diluted 1/100 in 0.05% PBS-Tween. 
The blots were then washed three times in 0.05% PBS- 
Tween and incubated for 60 min. at 37OC in a 1/1000 
dilution of horseradish peroxidase-conjugated rabbit 
anti-horse IgG (ICN Biomedicals, Inc, Costa Mesa, 
CA) or anti-human IgG (Dakopatts, Glostrup, 
Denmark). After the sheets were washed, the substrate 
4-chloro-1-naphthol (Bio-Rad, Laboratories Rich- 
mond, CA) was used for immunoenzymatic detection. 
The development of the reaction was stopped with 
distilled water. 
Plasmid isolation 
The 85-kb plasmid was isolated from R. equi by the 
alkaline lysis method as decribed by Takay et a1 (8). 
The bacteria were incubated at 37°C for 2 h in a 
buffer containing 0.05 M TRIS hydrochloride, 0.01 M 
EDTA, 0.05 M NaCl and 20% (wt/vol) sucrose (pH 
8.0) plus 5 m g / d  lysozyme. Cells were lysed in 3.0% 
(wt/vol) SDS in 0.05 M TRIS hydrochloride buffer 
(pH 12.6) at  55OC for 2 h. Chromosomal DNA 
was precipitated with 5 M potassium acetate buffer 
(pH 4.8) and centrifuged at 10,000 g for 15 min. The 
aqueous upper phase was recovered and purified DNA 
was precipitated with 0.6 volumes of cold isopropanol 
for 15 min at room temperature and centrifuged at 
10,000 g for 15 min. at O O C .  After washing with 70% 
ethanol, the DNA pellet was resuspended in 50 mM 
TRIS - 20 mM disodium EDTA, pH 8.0 (TE buffer) 
and analyzed by 0.8% agarose gel electrophoresis. 
Plasmids were visualized by ethidium bromide staining. 
Results 
lmmunoblot and plasmid analysis 
Immunoblots of the 7 R. equi clinical isolates and 
reference strain ATCC 33701 are shown in figure 1A. 
The foal-infected serum had an intense immuno- 
reactivity with the 15- to 17-kDa antigens of the 
reference strain ATCC 33701. When whole-cell 
antigens of the R. equi strains isolated from the patients 
were evaluated for their immunoreactivity, a diffuse 
band, corresponding in molecular mass to the 15- to 
17-kDa virulence-associated proteins, was strongly 
recognized by the infected-foal serum in only one 
clinical isolate (strain 239D). No differences were 
detected among the other components of the whole- 
cell antigens of all examined strains. The analysis of 
the plasmid profiles revealed that R. equi 239D also 
contained an approximately 85-kb plasmid, which 
corresponded in size to the virulence plasmid from 
ATCC 33701 (figure 1B). 
The immunoblot analysis of the human antibody 
response showed that serum samples from all but one 
AIDS patient reacted with several components of 
R. equi antigens, but not with the diffuse 15- to 17- 
kDa proteins (figure 2). In addition, the AIDS patient 
infected with strain 2 3 9 9  which showed the 15- to 17- 
kDa antigens in immunoblotting with infected-foal 
serum, exibited no serological reactivity with these 
proteins. 
Correlation with clinical findings 
The correlation between the R. equi isolates and the 
clinical outcome of R. equi infection in the 7 AIDS 
patients is reported in Table 1. Clinical isolate 239D, 
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Figure 1 lmmunoblot (A) and plasmid (8) profiles of R. eqoistrains. The virulence-associated 15- to 17-kDa antigens were 
detected by immunoblotting with naturally infected foal serum. Plasmid DNA was isolated, analyzed on a 0.8% agarose gel, 
and stained with ethidium bromide. Lanes: 1, strain 56830; 2, strain 212B; 3, strain 239D; 4, strain 22758; 5, strain 2633C; 6, strain 
210D; 7, strain 6058; 8, strain ATCC 33701. Arrow at  right indicates band for 15- to  17-kOa antigens. Abbreviations: 
pl=85-kb plasmid; chr=chromosomal DNA. 
carrying the 85-kb plasmid and expressing the 
virulence-associated antigens, was obtained from a 28- 
year-old man who presented with a 3-week history of 
fever, malaise, weight loss (8 kg) and a non-productive 
cough. A chest X-ray showed a large consolidation 
with cavity in the lower lobe of the right lung. Afier 
isolation of R. equi from the induced sputum, antibiotic 
treatment was given without benefit, and a chest 
radiography revealed progressive enlargement of the 
area of cavitation and a pleural effusion. The patient 
died 4 weeks later. 
As for the other clinical isolates which did not 
express virulence-associated antigens and plasmid, 4 
(strains 5683D, 2275B, 210Q 605B) were from AIDS 
patients with cavitary pneunionia which completely 
cleared up with antibiotics. After a clinical follow-up 
of at least 14 months, 3 of these patients (No. 1, 6 
and 7) were still free of pulmonary disease, while one 
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Figure 2 lmmunoblot analysis of serological antibody response to  R. equi in AIDS patients infected with avirulent (lanes 
1-6) and virulent R. equi(lane 7). The ATCC 33701 reference strain was used for the preparation of whole-cell antigens. Lanes 
1, 2, 4 and 5: recovered patients; lane 6: patient with asymptomatic R. equi infection; lanes 3 and 7: patients who died from 
R. equi pneumonia. Numbers at right indicate molecular mass. 
paticnt (No. 4) showed evidence ofa pulmonary relapse 
and K .  equi was again cultured from the sputum. This 
isolate was still lacking expression of the virulence 
antigens and presence of the plasmid encoding them 
(data not  shown). I t  had the same antibiotic suscepti- 
bility as the original strain. After 3 weeks of antibiotic 
therapy with erythroniycin, rifampicin, iniipeneni/ 
cilastatin and teicoplanin, the patient made a complete 
clinical and radiologic recovery. 
Clinical isolate 21 2B was obtained from a 29-year- 
old female who was hospitalized because of fever, 
productive cough, moderate dyspnea and radiologic 
evidence of a cavitated infiltration in the lower lobe of 
the right lung. She responded to treatment during 
the initial 4 weeks of therapy with rifanipicin and 
erythroniycin, which produced a reduction of radio- 
graphic infiltration. Then, pulmonary disease pro- 
gressed despite addition of imipeneni/cilastatin and 
teicoplanin and the patient’s clinical condition 
deteriorated with onset of respiratory failure followed 
by death. Interestingly it was this patient who had weak 
seroreactivity with all the major antigenic deterniinants 
of R. equi. 
Table 1 Correlation between the fl. equi isolates and the clinical outcome of R. equi infection in the 7 AIDS patients. 
Clinical 
isolate Patient Animal CD4+ CD8+ Clinical/X- ra y 
No. N o .  A,qe/scx exposure cells/pLI c.ells/p/ presentation A ntihiotics O i t  fcome 
s w r i  1 37 /M None 18 456 Cavit~ting pneumonia Ery, Rif  Kccovered, 
212n 2 2Y/F None 9 126 Cavitating pneumonia Ery, Rif,  Imp, Tcc IXed 
239L> 3 28/M None 5 977 Cavitating pncuinonia Ery, Ktf, Imp, Van Died 
2 2 7 . i ~  4 38/M Hones 7 108 Cavitating pricumonia Ery, Kif, Imp, Tec, Kelapre, 
survived 
wrvived 
2633C 3 34/M None 1s SO0 Asymptomatic infection None Survived 
21OD 6 33/M None 9 801 Cavitating pne~niionia Ery, Rif, Cip, Imp Re<-overed, 
605n 7 22/M None 32 1561 Cavitating pneumonia Ery, Kif, Cip, Imp Recovered, 
survived 
survived 
Abbreviations: Ery=erythroniycin; Kif=ri€ampicin; Cip=ciproAoxacin; Imp=imipcnem/cilastdtin; Tec=teicoplanin; Vaiz=vancomycin 
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Finally, the sixth R. equi strain (2633C), lacking 
both virulence proteins and plasmid, was isolated from 
the sputum of an AIDS patient who did not show any 
clinical and radiologic evidence of either pulmonary or 
extrapulmonary rhodococcal disease. 
Discussion 
Previous investigations have demonstrated that rhodo- 
coccal disease in horses correlates with the isolation 
of R. equi strains which contain an 85-kb plasmid, 
express 15- to 17-kDa antigens and are virulent in 
mice, whereas strains lacking both proteins and plasmid 
are avirulent and do not cause disease (3,4). The present 
paper provides evidence that the development of 
R. equi disease in AIDS patients doesn’t correlate with 
the isolation of strains expressing the 15- to 17-kDa 
plasmid-encoded antigens from biological specimens 
and, furthermore, that plasmid-negative strains may 
induce clinical illness. Indeed, of the six patients 
infected with the 85-kb plasmid-negative strains, only 
one did not show any clinical evidence of rhodococcal 
disease, while the other 5 developed cavitary pneu- 
monia. Similar findings were obtained by Takai and 
colleagues (9) who reported that opportunistic infections 
in immunocompromised patients with and without 
AIDS can be caused by both virulent and avirulent 
R. equi strains. However, these authors do not correlate 
the presence of bacterial virulence factors with the 
clinical course of rhodococcal disease. In the present 
study all but one patient infected with plasmid-negative 
R. equi strains recovered from the pulmonary disease, 
while the only patient infected with a strain expressing 
both virulence-associated 15- to 17-kDa antigens and 
the 85-kb plasmid had a severe and eventually fatal 
pneumonia. Our findings suggest that R. equi disease 
can be induced without the expression of the 15- to 
17-kDa virulence-associated plasmid-encoded antigens 
in HIV-infected patients with very low CD4+ cell 
counts (<35/~1) .  
The 15- to 17-kDa plasmid-encoded antigens 
represent important virulence factors in R. equi infec- 
tions in foals. These proteins are produced in vivo by 
virulent R. equi, are highly immunogenic in infected 
foals, and might be involved in the intracellular survival 
and replication of the bacterium within horse alveolar 
macrophages (10). The function and the immunologic 
properties of the 15- to 17-kDa antigens in human 
R. equi infections appear to be different from that 
reported in horses. Our work firstly suggests that the 
expression of virulence-associated plasmid-encoded 
antigens by R. equi does not seem to be essential for 
the development of clinical disease in AIDS patients. 
Secondly, although expressed by R. equi human isolates, 
the virulence proteins do not evoke a specific antibody 
response in infected patients. Indeed, our immuno- 
blotting experiments demonstrated that AIDS patients 
infected with R. equi may produce serum antibodies 
that react with various antigenic determinants of the 
bacterium but do not recognize the diffuse band 
corresponding to the 15- to 17-kDa proteins. The 
importance of humoral immunity in protection against 
R. equi disease has been emphasized by experimental 
data concerning the immune response ofhorses (1 1-13). 
Moreover, we recently demonstrated that the clinical 
outcome of R. equi pneumonia was more severe in 
AIDS patients who exhibited a negligible humoral 
immune response to R. equi (14). The results of the 
present study showed that among the 6 AIDS patients 
infected with R. equi strains lacking both virulence 
proteins and plasmid, the only one who did not recover 
from pneumonia showed a decreased antibody 
reactivity to R. equi antigenic components. 
The pathophysiology of R. equi infection in 
humans has yet to be elucidated. The role of animals in 
the transmission of the infection appears to be limited 
since the majority of patients have had no history of 
contact with farm animals or manure. Among the 7 
patients described here, only one (14%) had had recent 
exposure to horses. Our recent data on the detection 
of R. equi antibodies in AIDS patients without R. equi 
disease and in healthy individuals suggest that exposure 
to this organism is widespread in the environment (1 4). 
In AIDS patients, the impairment of T-cell-mediated 
immunity is clearly the critical determinant for the 
development of R. equi disease, which can be induced 
by both virulent and avirulent strains. Both CD4+ and 
CD8+ lymphocytes are important in the resistance 
against R. equi, even though CD8+ cells seem to play 
the major role in host defence (15). The results reported 
here suggest that, once infection is established, both the 
synthesis of the virulence-associated antigens and a 
defective humoral immune response may contribute to 
the severity of the disease. If the patients are infected 
with avirulent strains, the humoral immunity seems to 
have an important finction in the recovery fiom the 
opportunistic infection. Indeed, since the impaired 
production of specific antibodies reduces the opsoni- 
zation of bacteria, the uptake, phagosome-lysosome 
fusion and killing of R. equi by macrophages and 
neutrophils might be altered. In the case of infection 
with virulent strains, the disease outcome may be 
affected by the production of virulence factors which 
enhance the replicative capacity and prolong the 
survival of the organism within macrophages. In this 
respect, the 15- to 17-kDa plasmid-encoded proteins, 
which are not recognized by antibody-mediated 
immunity, may mediate R. equi intramacrophage 
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persistence, even if the involvement of other cell 
wall components, such as mycolic acids or toxic 
factors related to p-lactam resistance (16-18), cannot 
be excluded. 
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